Derivative Financial Instruments |
6 Months Ended |
|---|---|
Jun. 30, 2025 | |
| Derivative Financial Instruments | |
| Derivative Financial Instruments | Note 9 – Derivative Financial Instruments
The Company has derivative financial instrument liabilities of $13.1 million and $7.0 million, as of June 30, 2025 and December 31, 2024, respectively, related to the Private Warrants. The Company uses the share price of its Public Warrants as the input for the recurring fair value measurement of Private Warrants at the end of each reporting period within the “Derivative financial instruments” line item of the condensed consolidated balance sheets. The Public Warrants are used to remeasure the fair value as they have similar key terms. Refer to Note 8 and 10 for additional information.
During the six months ended June 30, 2025 and 2024, a loss of $6.2 million and gain of $8.4 million, respectively, were recognized within the “(Loss) gain from derivative liabilities” line in the condensed consolidated statements of operations. The change in fair value is included under operating activities within the condensed consolidated statements of cash flows. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|